Exploring complex and heterogeneous correlations on hypergraph for the prediction of drug-target interactions

被引:15
作者
Ruan, Ding [1 ]
Ji, Shuyi [2 ,3 ]
Yan, Chenggang [1 ]
Zhu, Junjie [2 ]
Zhao, Xibin [2 ]
Yang, Yuedong [4 ]
Gao, Yue [2 ,3 ]
Zou, Changqing [5 ]
Dai, Qionghai [3 ,6 ]
机构
[1] Hangzhou Dianzi Univ, Sch Automat, Hangzhou, Peoples R China
[2] Tsinghua Univ, Sch Software, BNRist, KLISS, Beijing, Peoples R China
[3] Tsinghua Univ, Inst Brain & Cognit Sci, Beijing, Peoples R China
[4] Sun Yat Sen Univ, Sch Comp Sci, Guangzhou, Peoples R China
[5] Huawei Canada Technol, Huawei Vancouver Res Ctr, Vancouver, BC, Canada
[6] Tsinghua Univ, Dept Automat, Beijing, Peoples R China
来源
PATTERNS | 2021年 / 2卷 / 12期
基金
中国国家自然科学基金;
关键词
PHARMACOLOGY; NETWORKS; IDENTIFICATION; CELIPROLOL;
D O I
10.1016/j.patter.2021.100390
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
The continuous emergence of drug-target interaction data provides an opportunity to construct a biological network for systematically discovering unknown interactions. However, this is challenging due to complex and heterogeneous correlations between drug and target. Here, we describe a heterogeneous hypergraph-based framework for drug-target interaction (HHDTI) predictions by modeling biological networks through a hypergraph, where each vertex represents a drug or a target and a hyperedge indicates existing similar interactions or associations between the connected vertices. The hypergraph is then trained to generate suitably structured embeddings for discovering unknown interactions. Comprehensive experiments performed on four public datasets demonstrate that HHDTI achieves significant and consistently improved predictions compared with state-of-the-art methods. Our analysis indicates that this superior performance is due to the ability to integrate heterogeneous high-order information from the hypergraph learning. These results suggest that HHDTI is a scalable and practical tool for uncovering novel drug-target interactions.
引用
收藏
页数:12
相关论文
共 56 条
[1]  
[Anonymous], 2006, P 23 INT C MACH LEAR, DOI 10.1145/1143844.1143874
[2]  
Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI [10.1093/nar/gkw1099, 10.1093/nar/gkh131]
[3]  
Bagherian M, 2021, BRIEF BIOINFORM, V22, P247, DOI 10.1093/bib/bbz157
[4]   Network medicine: a network-based approach to human disease [J].
Barabasi, Albert-Laszlo ;
Gulbahce, Natali ;
Loscalzo, Joseph .
NATURE REVIEWS GENETICS, 2011, 12 (01) :56-68
[5]   A standard database for drug repositioning [J].
Brown, Adam S. ;
Patel, Chirag J. .
SCIENTIFIC DATA, 2017, 4
[6]   Drug target identification using side-effect similarity [J].
Campillos, Monica ;
Kuhn, Michael ;
Gavin, Anne-Claude ;
Jensen, Lars Juhl ;
Bork, Peer .
SCIENCE, 2008, 321 (5886) :263-266
[7]   Assessing Drug Target Association Using Semantic Linked Data [J].
Chen, Bin ;
Ding, Ying ;
Wild, David J. .
PLOS COMPUTATIONAL BIOLOGY, 2012, 8 (07)
[8]   Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference [J].
Cheng, Feixiong ;
Liu, Chuang ;
Jiang, Jing ;
Lu, Weiqiang ;
Li, Weihua ;
Liu, Guixia ;
Zhou, Weixing ;
Huang, Jin ;
Tang, Yun .
PLOS COMPUTATIONAL BIOLOGY, 2012, 8 (05)
[9]   The Comparative Toxicogenomics Database: update 2019 [J].
Davis, Allan Peter ;
Grondin, Cynthia J. ;
Johnson, Robin J. ;
Sciaky, Daniela ;
McMorran, Roy ;
Wiegers, Jolene ;
Wiegers, Thomas C. ;
Mattingly, Carolyn J. .
NUCLEIC ACIDS RESEARCH, 2019, 47 (D1) :D948-D954
[10]  
Feng YF, 2019, AAAI CONF ARTIF INTE, P3558